Trial
NCT01101269
Effect of Angiotensin Converting Enzyme Inhibitor, Lisinopril, on Renal Blood Flow and Its Correlation With Proteinuria Reduction in Subjects With Type 2 Diabetes and Kidney Disease
UnknownTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Virginia
Collaborators
—
Condition
Type 2 Diabetes
Intervention
ACEI or ARB
Why stopped
Slow Recruitment
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-05-12